Anti-Fungal Activity of Cathelicidins and their Potential Role in Candida albicans Skin Infection
- 1 July 2005
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 125 (1) , 108-115
- https://doi.org/10.1111/j.0022-202x.2005.23713.x
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- The antimicrobial peptide LL-37 is expressed by keratinocytes in condyloma acuminatum and verruca vulgarisJournal of the American Academy of Dermatology, 2002
- Interleukin-1α and Interleukin-6 Enhance the Antibacterial Properties of Cultured Composite Keratinocyte GraftsAnnals of Surgery, 2002
- Cutaneous Injury Induces the Release of Cathelicidin Anti-Microbial Peptides Active Against Group A StreptococcusJournal of Investigative Dermatology, 2001
- The human antimicrobial and chemotactic peptides LL-37 and α-defensins are expressed by specific lymphocyte and monocyte populationsBlood, 2000
- Ll-37, the Neutrophil Granule–And Epithelial Cell–Derived Cathelicidin, Utilizes Formyl Peptide Receptor–Like 1 (Fprl1) as a Receptor to Chemoattract Human Peripheral Blood Neutrophils, Monocytes, and T CellsThe Journal of Experimental Medicine, 2000
- Diversity of antimicrobial peptides and their mechanisms of actionBiochimica et Biophysica Acta (BBA) - Biomembranes, 1999
- The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surfaceProceedings of the National Academy of Sciences, 1998
- Animal antimicrobial peptides: An overviewBiopolymers, 1998
- The Expression of the Gene Coding for the Antibacterial Peptide LL-37 Is Induced in Human Keratinocytes during Inflammatory DisordersJournal of Biological Chemistry, 1997
- Bacterial growth blocked by a synthetic peptide based on the structure of a human proteinase inhibitorNature, 1989